Zynex Shares outstanding
What is the Shares outstanding of Zynex?
The Shares outstanding of Zynex, Inc. is 38.500M
What is the definition of Shares outstanding?
Shares outstanding are all the shares of a corporation or of a financial asset that have been authorized, issued and purchased by investors and are held by them.
= issued shares - treasury shares
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Shares outstanding of companies in the Health Care sector on SZSE compared to Zynex
What does Zynex do?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES) device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. The company also supplies electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products; and distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers CM-1500, a blood volume monitor device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.
Companies with shares outstanding similar to Zynex
- Isagro S.p.A has Shares outstanding of 38.488M
- Cotec Corp has Shares outstanding of 38.489M
- TCI Express has Shares outstanding of 38.490M
- Odonate Therapeutics Inc has Shares outstanding of 38.490M
- TOM TAILOR SE has Shares outstanding of 38.495M
- IDEAYA Biosciences has Shares outstanding of 38.497M
- Zynex has Shares outstanding of 38.500M
- RepliCel Life Sciences has Shares outstanding of 38.531M
- Christopher & Banks has Shares outstanding of 38.546M
- CANCOM SE has Shares outstanding of 38.548M
- Astra Exploration Inc has Shares outstanding of 38.562M
- Pacific Coast Oil Trust has Shares outstanding of 38.583M
- Pacific Coast Oil Trust has Shares outstanding of 38.583M